KLOW is a single 80 mg lyophilized vial containing four compounds: GHK-Cu, BPC-157, TB-500 and KPV. GHK-Cu is the predominant component; exact proportions for the vial you receive are printed on that lot's certificate of analysis.

Each component is assayed by HPLC-UV at 220 nm for purity under USP , identity is confirmed by FTIR under USP , and bacterial endotoxin is measured by gel-clot LAL under USP . Testing is performed by an accredited third-party laboratory, not in house.

Why are these four compounds combined?

Each has been studied in a different part of the matrix-remodelling and inflammatory-signalling literature — copper transport and matrix remodelling, angiogenic and gastrointestinal models, actin sequestration, and melanocortin-pathway inflammatory signalling. Combining them into one vial is a formulation convenience for researchers designing multi-component protocols; it is not evidence of a combined effect.

Is KLOW for human use?

No. KLOW is supplied for research use only and is not for human or veterinary use.

Sequence	TKPRPGP
Length	7 residues
Formula	C₃₃H₅₇N₁₁O₉
Mol. weight	751.87 g/mol
CAS	129954-34-3
PubChem	11765600

Neuro

Selank

Selank is a synthetic heptapeptide developed at the Russian Institute of Molecular Genetics, designed as a stable analog of the endogenous tetrapeptide tuftsin. Its sequence appends a Pro-Gly-Pro tail to the tuftsin core (TKPR) for resistance to enzymatic degradation.

Molecular structure

Sequence TKPRPGP

What it has been studied for

Research interest centers on anxiolytic-pathway models, GABAergic and serotonergic-system interactions, and pre-clinical cognition paradigms. Selank has been the subject of multiple Russian-language publications and Western-translated reviews.

References

Citations for this compound are being verified against the primary sources before they are listed. Nothing appears here until it has been checked.

Back to Selank

For Research Use Only. Not for human or veterinary use.